1.
Mesti T, Bouchemal N, Banissi C, Nawfal Triba M, Marbeuf-gueye C, Cemazar M, et al. NMR Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells. Radiol Oncol [Internet]. 2018 Dec. 17 [cited 2026 Jun. 12];52(4). Available from: https://www.radioloncol.com/index.php/ro/article/view/2963